Global Cluster Headache Market Size to Grow USD 626 Billion By 2030 | CAGR of 6.5%

Global Cluster Headache Market Size to Grow USD 626 Billion By 2030

According to a research report, published by Spherical Insights & Consulting, the Global Cluster Headache Market Size to Grow from USD 355.2 Billion in 2021 to USD 626.0 Billion by 2030, at a CAGR of 6.5% during the forecast period. The growth of the elderly population, the rising incidence and prevalence of cluster headache syndrome, and the development of new technologies in the healthcare sector are the primary factors driving the market growth.

The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic situation has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19’s global impact has shown that interconnectedness plays an important role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI.

Browse key industry insights spread across 240 pages with 102 market data tables and figures & charts from the report “Global Cluster Headache Market Size, Share, and COVID-19 Impact Analysis By Type (Episodic and Chronic), By Route of Administration (Oral, Intravenous, Topical, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.” 

in detail along with the table of contents https://www.sphericalinsights.com/reports/cluster-headache-market

The chronic segment to account for the largest market size during the forecast period

Based on the type, the Cluster Headache Market is categorized into Episodic and Chronic. The chronic segment accounts for the largest market size during the forecast period. The chronic type of cluster headache affects most patients. The episodic form of the cluster headache may progress over time into the chronic form, or it may be chronic from the beginning, which propels the segment’s growth.

Intravenous segment to to hold higher CAGR during the forecast period

Based on route of administration type, the Cluster Headache Market is categorized into Oral, Intravenous, Topical, and Others. The intravenous segment to to hold higher CAGR during the forecast period. The growth of the intravenous market is anticipated to be driven by factors such as the rising use of the intravenous drugs in treating cluster headaches.

The hospital segment to hold a higher CAGR during the forecast period.

Based on the distribution channel, the Cluster Headache Market is categorized as Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. The hospital segment to hold a higher CAGR during the forecast period. Hospital pharmacies are expected to have a high growth rate owing to the increase in both private and public hospital pharmacies' funding for the treatment of cluster headaches, as well as an accompanying rise in awareness for the need for early diagnosis. These are the primary reasons driving the expansion of this segment.

Asia Pacific to hold a higher CAGR during the forecast period.

The Cluster Headache market has been segmented into five major regions: North America, Europe, APAC, Latin America, and MEA. The Asia Pacific is estimated to account for the highest market share in 2021. The cluster headache market in the Asia Pacific region has been growing owing to people's increased lifestyle and a large population pool in the region. Furthermore, the increased investment in the development of health infrastructure, in addition to a growing population base of senior citizens, adds impetus to the market’s growth. North America is expected to provide significant growth opportunities over the forecast period. The advanced healthcare infrastructure in the North American region and the emergence of advanced technology to diagnose the disease propel the market’s growth in the region. Furthermore, the rising prevalence of migraines is the primary factor contributing to the region's increasing share of the global cluster headache market.

Major vendors in the global Cluster Headache market include AstraZeneca Plc., Autonomic Technologies, Inc., ElectroCore Medical LLC, GlaxoSmithKline Plc., Winston Pharmaceuticals Inc., Zosano Pharma, Eli Lily and Company, Lundback Seattle BioPharmaceutical, Novartis AG, Takeda Pharmaceutical Company Limited, Grünenthal, AbbVie Inc., Allergan, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd, Amgen Inc., Merck & Co., Inc., Sun Pharmaceutical Industries Ltd, Amgen Inc

Recent Development

• In December 2019, Eli Lilly and Company, get approval from food and drug administration on Galcanezumab, which is used as an antibody for cluster headaches.

• In June 2019, Emgality (galcanezumab-gnlm) solution for injection was approved by the US Food and Drug Administration for the treatment of episodic cluster headaches in adults.

• In June 2019, To transfer the rights to its two neurology medications, Zembrace and Tosymra, Dr. Reddy's Laboratories, an Indian multinational pharmaceutical company, signed an asset purchase agreement with Upsher-Smith, a generics company with headquarters in the U.S. These medications are used to treat migraine and cluster headaches, respectively, and can be given orally, topically, intravenously, and in other ways.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global cluster headache market based on the below-mentioned segments:

Global Cluster Headache Market, By Type

• Episodic
• Chronic

Global Cluster Headache Market, By Route of Administration

• Oral
• Intravenous
• Topical
• Others

Global Cluster Headache Market, By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Cluster Headache Market, Regional Analysis

• North America
  • THE US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• The Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter